(Q28290785)

8

object named as

Marie-Christine Copin

0 references

Catherine Guettier

4

object named as

Catherine Guettier

0 references

author name string

Bettina Fabiani

1

0 references

Alain Delmer

2

0 references

Eric Lepage

3

0 references

Tony Petrella

5

0 references

Josette Brière

6

0 references

Anne-Marie Penny

7

0 references

Jacques Diebold

9

0 references

Felix Reyes

10

0 references

Philippe Gaulard

11

0 references

Thierry J Molina

Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2

12

0 references

language of work or name

English

0 references

publication date

December 2004

0 references

published in

Virchows Archiv

0 references

volume

445

0 references

issue

6

0 references

page(s)

545-51

0 references

cites work

1 reference

12 December 2020

CD10 expression and survival

1 reference

12 December 2020

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

12 December 2020

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

12 December 2020

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

1 reference

12 December 2020

Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes

1 reference

12 December 2020

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.

1 reference

12 December 2020

The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma

1 reference

12 December 2020

CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.

1 reference

12 December 2020

Analysis of immunoglobulin VH genes in CD10-positive diffuse large B-cell lymphoma

1 reference

12 December 2020

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

12 December 2020

Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-Cell lymphomas

1 reference

12 December 2020

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

1 reference

12 December 2020

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

12 December 2020

Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma

1 reference

12 December 2020

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

1 reference

12 December 2020

CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles

1 reference

12 December 2020

CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma

1 reference

12 December 2020

Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma

1 reference

12 December 2020

Diffuse large cell lymphoma

1 reference

12 December 2020

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

12 December 2020

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

12 December 2020

Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma

1 reference

12 December 2020

Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma

1 reference

12 December 2020

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

12 December 2020

CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas

1 reference

12 December 2020